Efficacy and Tolerability of Valganciclovir 6 Months Vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial. CLINICMED 2022, 3 (1), 18-25. https://doi.org/10.24018/clinicmed.2022.3.1.122.